Life Sciences

TDR’s Top 5 Psychedelic Developments For The Week of June 22

Jun 27, 2020

Champignon Brands Issued Cease Trade Order By B.C. Securities Commission

Jun 21, 2020

TDR’s Top 5 Psychedelic Developments For the Week of June 15

Jun 20, 2020

Johnson & Johnson’s Nasal Spray is the First Major Innovation in Depression Drugs since Prozac

Jun 17, 2020

A Tale of Two Sessions as Numinus Receives Key License Amendment From Health Canada

Jun 12, 2020

Cybin Corp.: Looking to Bring Mushrooms to the Mainstream

Jun 8, 2020

Modernizing Old Medicine to Treat COVID-19

Jun 4, 2020

Will Psychedelics Outperform Cannabis? Bruce Linton Explains

May 29, 2020

Red Light Holland Appoints Bruce Linton as Chairman of Advisory Board

May 27, 2020

Psychedelic Sector Image Battling to Overcome Cannabis’ Nasty Legacy

May 26, 2020

Mind Medicine Becomes 1st Exchange-Traded Psychedelics Company To Begin Phase 2A Trials

May 15, 2020

Revive Therapeutics Zeros In On Key Therapeutic Drug Candidate

May 13, 2020

Antibe Therapeutics Key Phase 2 Data Release Approaches the Home Stretch

Apr 5, 2020

Mind Medicine Inc. Smashes NEO Exchange New Listing Volume Record

Mar 3, 2020

Antibe Therapeutics Second Drug Candidate Meets Primary Endpoint

Feb 26, 2020

Mind Medicine Inc.: The Next Speculative Psychedelics Unicorn?

Feb 24, 2020

Could the Answer to the Opioid Crisis Be a Psychedelic?

Jan 15, 2020